Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Peri-Strips Dry (PSD) Veritas Collagen Matrix Staple Line Reinforcement for Colorectal Surgery

This study has been completed.
Sponsor:
Collaborator:
Synovis Surgical Innovations
Information provided by (Responsible Party):
Baxter Healthcare Corporation
ClinicalTrials.gov Identifier:
NCT00559013
First received: November 14, 2007
Last updated: April 4, 2017
Last verified: April 2017
Results First Received: December 15, 2009  
Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment;   Masking: No masking;   Primary Purpose: Prevention
Condition: Colorectal Cancer
Intervention: Device: Staple line reinforcement

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
38 subjects were recruited from two principal investigators and their respective surgical hospitals in the US from approximately February 2007 through October 2008.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
Subjects were excluded from the study if the met any of the exclusion criteria including having a a body mass index greater than 35, a history of Chron's Disease, or stage IV cancer. There was no washout, run-in or transition period to this study.

Reporting Groups
  Description
PSD Veritas Collagen Matrix Reinforcement Arm Subjects receiving PSD Veritas Collagen Matrix for staple line reinforcement when undergoing open or laparoscopic colorectal surgery requiring the creation of an anastomosis.

Participant Flow:   Overall Study
    PSD Veritas Collagen Matrix Reinforcement Arm
STARTED   38 
COMPLETED   38 
NOT COMPLETED   0 



  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
  Description
PSD Veritas Collagen Matrix Reinforcement Arm Subjects receiving PSD Veritas Collagen Matrix for staple line reinforcement when undergoing open or laparoscopic colorectal surgery requiring the creation of an anastomosis.

Baseline Measures
   PSD Veritas Collagen Matrix Reinforcement Arm 
Overall Participants Analyzed 
[Units: Participants]
 38 
Age 
[Units: Participants]
Count of Participants
 
<=18 years      0   0.0% 
Between 18 and 65 years      27  71.1% 
>=65 years      11  28.9% 
Age 
[Units: Years]
Mean (Standard Deviation)
 57.26  (11.44) 
Sex: Female, Male 
[Units: Participants]
Count of Participants
 
Female      18  47.4% 
Male      20  52.6% 
Region of Enrollment 
[Units: Participants]
 
United States   38 


  Outcome Measures

1.  Primary:   Number of Participants With Major Colorectal Related Adverse Events: Leak, Stricture and Hemorrhage.   [ Time Frame: Discharge and 1 Month post surgery ]


  Serious Adverse Events


  Other Adverse Events


  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.


  More Information
  Hide More Information

Certain Agreements:  
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.


Results Point of Contact:  
Name/Title: Lesa Hobright-Turner, Director of Clinical Affairs
Organization: Synovis
phone: 651-796-7506
e-mail: lesa.hobrightturner@synovissurgical.com



Responsible Party: Baxter Healthcare Corporation
ClinicalTrials.gov Identifier: NCT00559013     History of Changes
Other Study ID Numbers: CP1011, Rev C
Study First Received: November 14, 2007
Results First Received: December 15, 2009
Last Updated: April 4, 2017